Compared with healthy people, HNSCC patients have higher levels of various exosomes that carry inhibitory proteins in plasma, such as PD-L1, CTLA-4, and cyclooxygenase-2 (COX-2), which can mediate immune suppression (94). This evidence concerns the gene CTLA4 and head and neck squamous cell carcinoma.